PEA & Quercetin
Natural health product licensed in Canada
- Other names
- P.E.A.k Circulatory System
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80099500
- Status
- Active licence
- Licence date
- 28 April 2020
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(2-Hydroxyéthyl)hexadécanamide Source : Palmitoyléthanolamide | 300 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Stéaryl fumarate de sodium, Palmitate d'ascorbyle, Hypromellose, Hydroxypropylcellulose, Poudre de racine de carotte
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 4 Tous les jours |
Uses authorised in Canada
This product may be used as an anti-inflammatory to help relieve chronic pain. It is a source of antioxidants and is used in herbal medicine as a capillary/blood vessel protectant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen.
Source
Official Health Canada record, licence 80099500
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.